CVRX
NASDAQ HealthcareCVRx, Inc. - Common Stock
Medical Devices
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
๐ Market Data
| Price | $7.97 |
|---|---|
| Volume | 344,896 |
| Market Cap | 209.70M |
| Beta | 1.120 |
| RSI (14-Day) | 52.2 |
| 200-Day MA | $8.04 |
| 50-Day MA | $8.00 |
| 52-Week High | $11.30 |
| 52-Week Low | $4.30 |
| Forward P/E | -4.26 |
| Price / Book | 5.33 |
๐ฏ Investment Strategy Scores
CVRX scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Moon Shot (66/100) โ this strategy High growth potential (high beta + oversold).
Lowest fit among scored strategies: ๐ Institutional Whale (3/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find CVRX in your text
Paste any article, transcript, or post โ the tool will extract CVRX and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.